Author:
Anagostou Anthanasia,Liotta Lance A.
Reference39 articles.
1. Mamounas, E. P., Tang, G., Fisher, B., Paik, S., Shak, S., Costantino, J. P. et al. (2010) Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 28, 1677–83.
2. Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W. et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24, 3726–34.
3. Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M. et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351, 2817–26.
4. American Hospital Association (2010) Fast Facts on US Hospitals. American Hospital Association: Chicago, IL, http://www.aha.org/aha/content/2010/pdf/101207fastfacts.pdf Accessed 16 February 2011
5. Batchelder, K., Miller, P. (2006) A change in the market--investing in diagnostics. Nat Biotechnol 24, 922–6.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献